Novamab cooperates with pharmaceutical enterprise customers for products with relatively complete development content, and transfers the development rights and interests agreed in the development project to the customer. Novamab obtains the corresponding amount and profit proportion of the cooperation mode according to the relevant progress (milestones) achieved by the customer, and the intellectual property rights belong to both parties according to the contract.

Novamab and its customers jointly participate in the project design, take charge of the project implementation and promotion in their respective fields of expertise, jointly undertake the development risks, jointly undertake the project funds, and share the intellectual property rights and benefits.

Novamab is willing to establish a primary order contract mode of one-time transaction with customers. Loqi Biotech provides raw materials and services, and customers pay development costs. Cooperative customers have complete intellectual property rights.